More on MRX
Data
Financials
News
|
Medicis Pharmaceutical Corp. (NY:MRX)
Delayed: 43.98
--0 (-0%)
|
Trade Now! |
|
| Previous Close |
$43.98 |
|
52 Week High |
$44.00 |
|
| Open |
$32.66 |
|
52 Week Low |
$30.30 |
| Day High |
$43.98 |
|
P/E |
63.74 |
| Day Low |
$43.98 |
|
EPS |
$0.69 |
| Volume |
5,070 |
|
|
|
-
Dec 5, 2012 05:18 PM
UPDATE: Garmin (GRMN) to replace RR Donnelly in S&P 500
-
Dec 5, 2012 04:06 PM
Valeant Pharma (VRX) Reaches Agreement with Galderma; Will Make Upfront Payment (MRX)
-
Nov 28, 2012 08:05 AM
Valeant (VRX) Names Two New EVPs
-
Nov 16, 2012 07:52 AM
Valeant (VRX) Receives FTC Clearance to Acquire Medicis Pharma (MRX)
-
Nov 9, 2012 02:11 PM
Medicis (MRX) Slumps as Q-Med Takes Up Lawsuit (VRX)
-
Sep 24, 2012 08:22 AM
Susquehanna Downgrades Medicis (MRX) to Neutral
-
Sep 21, 2012 08:02 AM
Medicis Pharmaceutical Corp. (MRX) Declares $0.10 Quarterly Dividend; 0.9% Yield
-
Sep 13, 2012 05:31 PM
Valeant Pharma (VRX) COO De Silva to Leave Company
-
Sep 7, 2012 04:21 PM
Top 10 News Items 09/04 - 09/07: Where Are the Jobs?; Draghi Fires-Up Markets; Facebook CEO Pauses on Sales; Intel Issues Warning
-
Sep 7, 2012 07:21 AM
Jefferies Maintains a 'Buy/Top Pick' on Valeant Pharmaceuticals (VRX); Taking the Right Medic(is)ine
View All Articles
-
Dec 5, 2012 05:18 PM
UPDATE: Garmin (GRMN) to replace RR Donnelly in S&P 500
-
Dec 5, 2012 04:06 PM
Valeant Pharma (VRX) Reaches Agreement with Galderma; Will Make Upfront Payment (MRX)
-
Nov 28, 2012 08:05 AM
Valeant (VRX) Names Two New EVPs
-
Nov 16, 2012 07:52 AM
Valeant (VRX) Receives FTC Clearance to Acquire Medicis Pharma (MRX)
-
Nov 9, 2012 02:11 PM
Medicis (MRX) Slumps as Q-Med Takes Up Lawsuit (VRX)
-
Sep 24, 2012 08:22 AM
Susquehanna Downgrades Medicis (MRX) to Neutral
-
Sep 21, 2012 08:02 AM
Medicis Pharmaceutical Corp. (MRX) Declares $0.10 Quarterly Dividend; 0.9% Yield
-
Sep 13, 2012 05:31 PM
Valeant Pharma (VRX) COO De Silva to Leave Company
-
Sep 7, 2012 04:21 PM
Top 10 News Items 09/04 - 09/07: Where Are the Jobs?; Draghi Fires-Up Markets; Facebook CEO Pauses on Sales; Intel Issues Warning
-
Sep 7, 2012 07:21 AM
Jefferies Maintains a 'Buy/Top Pick' on Valeant Pharmaceuticals (VRX); Taking the Right Medic(is)ine
View All Reports